Document Type
Article
Publication Date
10-31-2025
Abstract
Embryonic Transcription Factors (TFs) are often reactivated in cancer, driving developmental gene programs that support phenotypic plasticity. Metabolic adaptation fuels this plasticity by supplying energy and molecular building blocks for growth. RUNX2, the master regulator of bone morphogenesis, is ectopically expressed in epithelial cancer, promoting metastasis through trans-differentiation processes like Epithelial-to-Mesenchymal Transition (EMT) and osteomimicry. By combining omics data with functional validation, we demonstrated that RUNX2 drives cancer cell metabolic rewiring by repressing mitochondrial respiration while promoting anabolic processes. We showed that RUNX2 upregulates key genes of lipid biosynthesis by regulating and cooperating with SREBP1. In vivo expression analysis in thyroid and breast cancer patients confirmed that lipid metabolism and SREBF1 expression are associated with increased metastatic potential and clinical aggressiveness. These findings emphasize the RUNX2 role in cancer plasticity and indicate metabolic adaptation as an integral part of the trans-differentiation program induced by this TF during cancer progression.
Recommended Citation
Vitale, Emanuele; Gugnoni, Mila; Manicardi, Veronica; Muccioli, Silvia; Torricelli, Federica; Donati, Benedetta; Piana, Simonetta; Manzotti, Gloria; Salviato, Elisa; Reggiani, Francesca; Ascione, Cristian; Vezzani, Rebecca; Ragazzi, Moira; Forcato, Mattia; Romano, Oriana; Bicciato, Silvio; Goldman, Aaron; Tigano, Marco; and Ciarrocchi, Alessia, "RUNX2 Cooperates With SREBP1 to Rewire Cancer Metabolism and Promote Aggressiveness" (2025). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 467.
https://jdc.jefferson.edu/pacbfp/467
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
41174748
Language
English
Included in
Amino Acids, Peptides, and Proteins Commons, Cancer Biology Commons, Genetic Phenomena Commons, Neoplasms Commons, Women's Health Commons


Comments
This article is the author’s final published version in Journal of Experimental and Clinical Cancer Research, Volume 44, Issue 1, 2025, Article number 298.
The published version is available at https://doi.org/10.1186/s13046-025-03549-7. Copyright © The Author(s) 2025.